Trials / Suspended
SuspendedNCT00181051
Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia
- Status
- Suspended
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 128 (planned)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Index computed in real time from Auditory Evoked Potentials have been described parallel to depth of anesthesia. The goal of the study was to compare general anesthesia guided on Auditory Evoked Potentials monitoring to standrad practice in order to assess if AEP monitoring can improve recovery delay (main criteria) or intraoperative hemodynamic stability (secondary criteria). Patients were randomized in 2 groups, stratified by center. Group I : AEP guided anesthesia, Group II: Blind AEP record, standard practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Alaris AEP monitor |
Timeline
- Start date
- 2003-02-01
- First posted
- 2005-09-16
- Last updated
- 2005-09-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00181051. Inclusion in this directory is not an endorsement.